 |
|
TB Picture Brightening, but Dark Spots Remain
Brian Vastag
JAMA. 2002;288:35.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Washington—A cluster of efforts against
tuberculosis (TB) had experts at the Fourth World Congress on Tuberculosis
sounding optimistic about a disease that still claims 2 million lives each
year. The expansion of prevention and control campaigns in China and India,
a renewed drive toward an adult vaccine, and the infusion of several hundred
million dollars into research and treatment have the world poised for "rapid
advances," said Philip Hopewell, MD, a TB researcher at the University of
San Francisco School of Medicine.
While those developments bode well, other speakers noted two ominous
trends, namely the emergence of TB in Eastern Europe and the 15 states of
the former Soviet Union, and the rise of multidrug-resistant strains. Worldwide,
some 3% of cases are drug-resistant, but in former Soviet states, which have
suffered from economic collapse, that figure reaches as high as 14%. In early
June, the World Health . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Minerva
BMJ 2002;325:172-172.
FULL TEXT
|
